Predictmedix AI Screening Technology Emerges as Strategic Asset Amid FDA's Regulatory Shift Away from Animal Testing

Stock Information for Predictmedix AI Inc Com

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Predictmedix AI Inc Com

Predictmedix AI Announces Closing of $460,150 First Tranche
Predictmedix AI Announces Non-Brokered Private Placement
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader
Predictmedix AI Expands into Mobile Diagnostics with New AI-Driven Diabetes Screening Platform
Predictmedix AI and Pacific Mechatronics Announce Strategic Commercial Alliance to Rapidly Scale AI Health Screening Across Asia-Pacific Defence Sector
Predictmedix AI to Headline Exclusive European Investor Roadshow Across Budapest, Zagreb, and Belgrade

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.